Carbamylated erythropoietin reduces radiosurgically-induced brain injury

Molecular Medicine

Volumn 12, Issue 4-6, 2006, Pages 74-80

  Erbayraktar, Serhat ^a   De Lanerolle, Nihal ^b   De Lotbinière, Alain ^b   Knisely, Jonathan P S ^b   Erbayraktar, Zubeyde ^a   Yilmaz, Osman ^a   Cerami, Anthony ^c   Coleman, Thomas R ^c   Brines, Michael ^c,d  

^a Textile Engineering Department   (Turkey)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Warren Pharmaceuticals Inc   (United States)

^d Kenneth S Warren Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMYLATED ERYTHROPOIETIN; CYTOKINE; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW; BRAIN INJURY; BRAIN NECROSIS; BRAIN TUMOR; CARBAMOYLATION; CONGENITAL BLOOD VESSEL MALFORMATION; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; ERYTHROPOIESIS; FORELIMB; GAMMA IRRADIATION; GAMMA KNIFE RADIOSURGERY; HEMATOPOIESIS; HISTOPATHOLOGY; IMMUNE RESPONSE; INFLAMMATION; MALE; MECHANICAL STIMULATION; MORALITY; MORBIDITY; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIATION INJURY; RADIOSURGERY; RAT; REFLEX; SYSTEMIC THERAPY; THROMBOSIS; TISSUE INJURY; TISSUE NECROSIS; TISSUE REPAIR; VIBRISSA;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN INJURIES; ERYTHROPOIETIN; GAMMA RAYS; MALE; NECROSIS; NEUROPROTECTIVE AGENTS; RADIOSURGERY; RATS; RATS, SPRAGUE-DAWLEY; STEREOTAXIC TECHNIQUES;

EID: 33749006605     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/2006-00042.Erbayraktar     Document Type: Article

References (33)

1. Denham JW, Hauer-Jensen M. (2002) The radiotherapeutic injury: a complex 'wound' Radiother. Oncol. 63:129-45.
2. Stone HB, Coleman CN, Anscher MS, McBride WH. (2003) Effects of radiation on normal tissue: consequences and mechanisms. Lancet Oncol 4:529-36.
3. Flickinger JC et al. (1999) A multi-institutional analysis of complication outcomes after arteriovenous malformation radiosurgery Int. J. Radiat. Oncol. Biol. Phys. 44:67-74.
4. Miyawaki L et al. (1999) Five year results of LINAC radiosurgery for arteriovenous malformations: outcome for large AVMS. Int. J. Radiat. Oncol. Biol. Phys. 44:1089-106.
5. Chuba PJ et al. (1997) Hyperbaric oxygen therapy for radiation-induced brain injury in children. Cancer 80:2005-12.
6. Giglio P, Gilbert MR. (2003) Cerebral radiation necrosis. Neurologist 9:180-8.
7. Koehler PJ, Jager J, Verbiest H, Vecht CJ. (1995) Anticoagulation for radiation injury. Neurology 45:1786.
8. Brines M, Cerami A. (2005) Emerging biological roles for erythropoietin in the nervous system. Nat. Rev. Neurosci. 6:484-94.
9. Coleman TR et al. (2006) Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activities. Proc. Natl. Acad. Sci. U. S. A. 103:5965-5970.
10. Leyland-Jones B. (2003) Breast cancer trial with erythropoietin terminated unexpectedly Lancet. Oncol. 4:459-60.
11. Rosenzweig MQ, Bender CM, Lucke JP, Yasko JM, Brufsky AM. (2004) The decision to prematurely terminate a trial of R-HuEPO due to thrombotic events. J. Pain Symptom Manage. 27:185-90.
12. Hoegler D. (1997) Radiotherapy for palliation of symptoms in incurable cancer. Curr. Probl. Cancer 21:129-83.
13. Masuda S et al. (1993) Functional erythropoietin receptor of the cells with neural characteristics: comparison with receptor properties of erythroid cells. J. Biol. Chem. 268:11208-16.
14. Brines M et al. (2004) Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proc. Natl. Acad. Sci. U. S. A. 101:14907-12.
15. Leist M et al. (2004) Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 305:239-42.
16. Kondziolka D, Lunsford LD, Claassen D, Maitz AH, Flickinger JC. (1992) Radiobiology of radiosurgery: Part I. The normal rat brain model. Neurosurgery 31:271-9.
17. Schallert T, Fleming SM, Leasure JL, Tillerson JL, Bland ST. (2000) CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 39:777-87.
18. Woodlee MT, Asseo-Garcia AM, Zhao X, Liu SJ, Jones TA, Schallert T. (2005) Testing forelimb placing "across the midline" reveals distinct, lesion-dependent patterns of recovery in rats. Exp. Neurol. 191:310-7.
19. Munter MW et al. (2001) [Late radiation changes after small volume radiosurgery of the rat brain. Measuring local cerebral blood flow and histopathological studies]. Strahlenther. Onkol. 177:354-61. (German)
20. Yang T, Wu SL, Liang JC, Rao ZR, Ju G. (2000) Time-dependent astroglial changes after gamma knife radiosurgery in the rat forebrain. Neurosurgery 47:407-15.
21. Andratschke N et al. (2006) Preclinical evaluation of erythropoietin administration in a model of radiation-induced kidney dysfunction. Int. J. Radiat. Oncol. Biol. Phys. 64:1513-8.
22. Shingo T, Sorokan ST, Shimazaki T, Weiss S. (2001) Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. J. Neurosci. 21:9733-43.
23. Tsai PT et al. (2006) A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery. J. Neurosci. 26:1269-74.
24. Fukuda H et al. (2004) Irradiation-induced progenitor cell death in the developing brain is resistant to erythropoietin treatment and caspase inhibition. Cell Death Differ. 11:1166-78.
25. Yu X et al. (2002) Erythropoietin receptor signaling is required for normal brain development. Development 129:505-16.
26. Diaz Z, Assaraf MI, Miller WH, Jr., Schipper HM. (2005) Astroglial cytoprotection by erythropoietin pre-conditioning: implications for ischemic and degenerative CNS disorders. J. Neurochem. 93:392-402.
27. Fukuda A et al. (2005) Age-dependent sensitivity of the developing brain to irradiation is correlated with the number and vulnerability of progenitor cells. J. Neurochem. 92:569-84.
28. Martinez-Estrada OM, Rodriguez-Millan E, Gonzalez-De Vicente E, Reina M, Vilaro S, Fabre M. (2003) Erythropoietin protects the in vitro blood-brain barrier against VEGF-induced permeability. Eur J. Neurosci. 18:2538-44.
29. Li W, Maeda Y, Yuan RR, Elkabes S, Cook S, Dowling P. (2004) Beneficial effect of erythropoietin on experimental allergic encephalomyelitis. Ann. Neurol. 56:767-77.
30. Uzum G, Sarper Diler A, Bahcekapili N, Ziya Ziylan Y. (2005) Erythropoietin prevents the increase in blood-brain barrier permeability during pentylentetrazol induced seizures. Life Sci. 22:2571-2576.
31. Kamiryo T, Lopes MB, Kassell NF, Steiner L, Lee KS. (2001) Radiosurgery-induced microvascular alterations precede necrosis of the brain neuropil. Neurosurgery 49:409-14.
32. Robbins ME, Diz DI. (2006) Pathogenic role of the renin-angiotensin system in modulating radiation-induced late effects. Int. J. Radiat. Oncol. Biol. Phys. 64:6-12.
33. Coleman CN et al. (2003) Molecular and cellular biology of moderate-dose (1-10 Gy) radiation and potential mechanisms of radiation protection: report of a workshop at Bethesda, Maryland, December 17-18, 2001. Radiat. Res. 159:812-34.